115 related articles for article (PubMed ID: 34318804)
1. When drug nanocarriers miss their target: extracellular diffusion and cell uptake are not enough to be effective.
Pautu V; Zhao H; Mielcarek A; Balasso A; Couvreur P; Serre C; Mura S
Biomater Sci; 2021 Aug; 9(16):5407-5414. PubMed ID: 34318804
[TBL] [Abstract][Full Text] [Related]
2. Formulation of Metal-Organic Framework-Based Drug Carriers by Controlled Coordination of Methoxy PEG Phosphate: Boosting Colloidal Stability and Redispersibility.
Chen X; Zhuang Y; Rampal N; Hewitt R; Divitini G; O'Keefe CA; Liu X; Whitaker DJ; Wills JW; Jugdaohsingh R; Powell JJ; Yu H; Grey CP; Scherman OA; Fairen-Jimenez D
J Am Chem Soc; 2021 Sep; 143(34):13557-13572. PubMed ID: 34357768
[TBL] [Abstract][Full Text] [Related]
3. Porous nanoparticles with engineered shells release their drug cargo in cancer cells.
Qiu J; Li X; Rezaei M; Patriarche G; Casas-Solvas JM; Moreira-Alvarez B; Costa Fernandez JM; Encinar JR; Savina F; Picton L; Vargas-Berenguel A; Gref R
Int J Pharm; 2021 Dec; 610():121230. PubMed ID: 34718091
[TBL] [Abstract][Full Text] [Related]
4. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
Yang B; Shen M; Liu J; Ren F
Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled multifunctional core-shell highly porous metal-organic framework nanoparticles.
Qiu J; Li X; Steenkeste K; Barroca-Aubry N; Aymes-Chodur C; Roger P; Casas-Solvas JM; Vargas-Berenguel A; Rihouey C; Picton L; Gref R
Int J Pharm; 2020 May; 581():119281. PubMed ID: 32276089
[TBL] [Abstract][Full Text] [Related]
6. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles of Metal-Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine.
Simon-Yarza T; Mielcarek A; Couvreur P; Serre C
Adv Mater; 2018 Sep; 30(37):e1707365. PubMed ID: 29876985
[TBL] [Abstract][Full Text] [Related]
8. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials.
Chen D; Yang D; Dougherty CA; Lu W; Wu H; He X; Cai T; Van Dort ME; Ross BD; Hong H
ACS Nano; 2017 Apr; 11(4):4315-4327. PubMed ID: 28345871
[TBL] [Abstract][Full Text] [Related]
10. Functional metal-organic framework-based nanocarriers for accurate magnetic resonance imaging and effective eradication of breast tumor and lung metastasis.
Meng Z; Huang H; Huang D; Zhang F; Mi P
J Colloid Interface Sci; 2021 Jan; 581(Pt A):31-43. PubMed ID: 32768733
[TBL] [Abstract][Full Text] [Related]
11. Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
Xu W; Lou Y; Chen W; Kang Y
Biomed Tech (Berl); 2020 Apr; 65(2):229-236. PubMed ID: 31605575
[TBL] [Abstract][Full Text] [Related]
12. Facile Fabrication of Redox-Responsive Covalent Organic Framework Nanocarriers for Efficiently Loading and Delivering Doxorubicin.
Liu S; Yang J; Guo R; Deng L; Dong A; Zhang J
Macromol Rapid Commun; 2020 Feb; 41(4):e1900570. PubMed ID: 31894599
[TBL] [Abstract][Full Text] [Related]
13. Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers.
Bellido E; Hidalgo T; Lozano MV; Guillevic M; Simón-Vázquez R; Santander-Ortega MJ; González-Fernández Á; Serre C; Alonso MJ; Horcajada P
Adv Healthc Mater; 2015 Jun; 4(8):1246-57. PubMed ID: 25771896
[TBL] [Abstract][Full Text] [Related]
14. Dual Roles of Metal-Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy.
Zhao H; Li T; Yao C; Gu Z; Liu C; Li J; Yang D
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6034-6042. PubMed ID: 33499584
[TBL] [Abstract][Full Text] [Related]
15. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
16. Design of Engineered Cyclodextrin Derivatives for Spontaneous Coating of Highly Porous Metal-Organic Framework Nanoparticles in Aqueous Media.
Cutrone G; Li X; Casas-Solvas JM; Menendez-Miranda M; Qiu J; Benkovics G; Constantin D; Malanga M; Moreira-Alvarez B; Costa-Fernandez JM; García-Fuentes L; Gref R; Vargas-Berenguel A
Nanomaterials (Basel); 2019 Aug; 9(8):. PubMed ID: 31374940
[TBL] [Abstract][Full Text] [Related]
17. Drug-Loaded Lipid-Coated Hybrid Organic-Inorganic "Stealth" Nanoparticles for Cancer Therapy.
Li X; Salzano G; Qiu J; Menard M; Berg K; Theodossiou T; Ladavière C; Gref R
Front Bioeng Biotechnol; 2020; 8():1027. PubMed ID: 33042960
[TBL] [Abstract][Full Text] [Related]
18. Facile Ultrasound-Triggered Release of Calcein and Doxorubicin from Iron-Based Metal-Organic Frameworks.
Ibrahim M; Sabouni R; Husseini GA; Karami A; Bai RG; Mukhopadhyay D
J Biomed Nanotechnol; 2020 Sep; 16(9):1359-1369. PubMed ID: 33419490
[TBL] [Abstract][Full Text] [Related]
19. Cellular fate and performance of group IV metal organic framework radioenhancers.
Neuer AL; Jessernig A; Gerken LRH; Gogos A; Starsich FHL; Anthis AHC; Herrmann IK
Biomater Sci; 2022 Nov; 10(22):6558-6569. PubMed ID: 36215095
[TBL] [Abstract][Full Text] [Related]
20. Highly Porous Hybrid Metal-Organic Nanoparticles Loaded with Gemcitabine Monophosphate: a Multimodal Approach to Improve Chemo- and Radiotherapy.
Li X; Porcel E; Menendez-Miranda M; Qiu J; Yang X; Serre C; Pastor A; Desmaële D; Lacombe S; Gref R
ChemMedChem; 2020 Feb; 15(3):274-283. PubMed ID: 31765517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
